Analyst Ratings for AbbVie
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have given their opinion on AbbVie (NYSE:ABBV) stock, with 2 being bullish and 3 somewhat bullish. The average price target is $179.4, implying an upside from the current price of $135.15. However, this average has decreased by 2.37% from the previous average price target of $183.75.
July 14, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on AbbVie with an average price target of $179.4, indicating potential upside from the current price.
The bullish sentiment from analysts, along with the average price target indicating an upside, suggests a positive short-term impact on AbbVie's stock. However, the decrease in the average price target could slightly dampen this positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100